PIA Investment Management

PIA Investment Management

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

South Korea, Seoul

About

The fund is located in South Korea, Asia. The primary office of this VC is located in Seoul.

The most common rounds for this fund are in the range of 10 - 50 millions dollars. The fund typically enters into less than 2 deals annually. The fund's activity peaked in 2018.

The fund typically invests in rounds with 3 participants. Along with PIA Investment Management, start-ups are often financed by SparkLabs Accelerator, WONIK Investment Partners, Softbank Ventures Asia. Other VCs who often invest in the same rounds are Green Cross, DAYLI Financial Group.

Moreover, a start-up needs to be 2-3 years old to get investment from this fund. Among the most popular investment industries for the fund are Biotechnology, InsurTech. However, the fund’s focus is not limited to this, since there are 4 more areas of investment. Genoplan is among the most popular portfolio start-up of the fund. The country of its foundation and the country of its most frequent investments doesn't coincide - United States.

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: lasalle.com; User name format in descending order of probability: first '.' last, first last, first '_' last, first_initial last, last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing Together

Green Cross, DAYLI Financial Group

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: